Alkem Labs - Alkem Laboratories Share Price

Alkem Labs - Alkem Laboratories Share Price

  • 5,286.50-13.00 (-0.25%)
  • Pre Open
  • As On: 11 Jun, 2026, 09:06 AM IST
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...
Try ETMarkets GPTNEW
Open5,305.00
High-
Low-
Prev Close5,299.50
Volume88
VWAP(₹)-

Key Metrics

PE Ratio(x)27.53
EPS - TTM(₹)192.51
MCap(₹ Cr.)63,363.47
MCap Rank12
PB Ratio(x)4.42
Div Yield(%)1.00
Face Value(₹)2.00
52W High(₹)5,933.50
52W Low(₹)4,716.20
MCap/Sales4.31
Beta(1 Month)0.18
BV/Share(₹)1,200.09

Alkem Labs share price insights

Rank 187 - ET 5002025 ranking

  • Intraday fact check

    In the last 10 years, only 0.54 % trading sessions saw intraday declines higher than 5 % .

  • Beating 3 Yr Revenue CAGR

    Company's annual revenue growth of 13.65% outperformed its 3 year CAGR of 8.89%. (Source: Consolidated Financials)

  • Candle Formations Yesterday

    Black Spinning Top was formed for Alkem Labs

  • Employee & Interest Expense

    Company has spent 1.09% of its operating revenues towards interest expenses and 19.28% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

  • Alkem Labs Share Price Update

    Alkem Laboratories Ltd. share price moved down by -0.25% from its previous close of Rs 5,299.50. Alkem Laboratories Ltd. stock last traded price is 5,286.50

    Share PriceValue
    Today/Current/Last5,286.50
    Previous Day5,299.50

Found Insights useful?

Alkem Labs Share Price Returns

1 Day-0.25%
1 Month-5.59%
3 Months-4.65%
1 Year8.21%
3 Years54.83%
5 Years65.35%

Alkem Labs Share Recommendations

Mean recosCurrent
BUY

18 Analysts

Strong
SellSellHoldBuyStrong
Buy
Analyst Trends
RatingsCurrent1W Ago1M Ago3M Ago
Strong Buy4444
Buy5544
Hold6678
Sell2222
Strong Sell11-1
# Analysts18181719
Recent Recos
  • Target₹5900
  • OrganizationICICI Securities
  • ADD
  • Target₹5700
  • OrganizationHDFC Securities
  • ADD
  • Target₹6180
  • OrganizationHDFC Securities
  • ADD
View all Stock Recommendations

News & Analysis

View all Alkem Labs Share News & Announcements

Financials

  • Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
    Total Income3,803.393,879.924,104.683,507.633,289.71
    Total Income Growth (%)-1.97-5.4817.026.62-5.12
    Total Expenses3,326.663,056.623,173.832,706.842,864.95
    Total Expenses Growth (%)8.83-3.6917.25-5.526.10
    EBIT476.73823.30930.85800.79424.76
    EBIT Growth (%)-42.10-11.5516.2488.53-44.63
    Profit after Tax (PAT)236.46636.02765.06664.26305.86
    PAT Growth (%)-62.82-16.8715.17117.18-51.13
    EBIT Margin (%)12.5321.2222.6822.8312.91
    Net Profit Margin (%)6.2216.3918.6418.949.30
    Basic EPS (₹)19.7753.1963.9955.5625.57
    Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
    Total Income2,464.132,622.802,643.402,488.752,156.53
    Total Income Growth (%)-6.05-0.786.2115.41-12.19
    Total Expenses2,111.801,901.141,829.941,796.291,839.79
    Total Expenses Growth (%)11.083.891.87-2.368.44
    EBIT352.33721.66813.46692.46316.74
    EBIT Growth (%)-51.18-11.2917.47118.62-58.29
    Profit after Tax (PAT)217.06622.14786.73656.16276.94
    PAT Growth (%)-65.11-20.9219.90136.93-61.70
    EBIT Margin (%)14.3027.5130.7727.8214.69
    Net Profit Margin (%)8.8123.7229.7626.3712.84
    Basic EPS (₹)18.1652.0365.8054.8823.17
    FY 2026FY 2025FY 2024FY 2023FY 2022
    Total Revenue15,295.6213,458.2612,978.4211,815.3410,796.84
    Total Revenue Growth (%)13.653.709.849.4318.67
    Total Expenses12,249.9010,931.2310,833.8010,407.598,937.60
    Total Expenses Growth (%)12.060.904.1016.4523.17
    Profit after Tax (PAT)2,301.802,165.481,795.77984.171,645.62
    PAT Growth (%)6.3020.5982.47-40.193.82
    Operating Profit Margin (%)21.7920.4317.8113.0617.97
    Net Profit Margin (%)15.6416.7014.178.4815.47
    Basic EPS (₹)192.51181.11150.1982.31137.63
    FY 2026FY 2025FY 2024FY 2023FY 2022
    Total Revenue10,219.089,320.5010,053.719,320.849,029.70
    Total Revenue Growth (%)9.64-7.297.863.2221.86
    Total Expenses7,553.377,016.968,108.857,993.857,276.33
    Total Expenses Growth (%)7.64-13.471.449.8631.99
    Profit after Tax (PAT)2,282.092,280.891,747.151,134.471,541.25
    PAT Growth (%)0.0530.5554.01-26.39-8.54
    Operating Profit Margin (%)28.1727.0020.7915.6020.28
    Net Profit Margin (%)23.6125.8717.9212.5217.45
    Basic EPS (₹)190.87190.77146.1394.88128.90

    All figures in Rs Cr, unless mentioned otherwise

    Insights

    • Beating 3 Yr Revenue CAGR

      Company's annual revenue growth of 13.65% outperformed its 3 year CAGR of 8.89%. (Source: Consolidated Financials)

    • Employee & Interest Expense

      Company has spent 1.09% of its operating revenues towards interest expenses and 19.28% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
    View Details
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Total Assets20,872.9717,691.1015,574.9013,756.6514,069.19
    Total Assets Growth (%)17.9913.5913.22-2.2222.14
    Total Liabilities6,524.045,257.474,860.504,321.655,221.86
    Total Liabilities Growth (%)24.098.1712.47-17.2431.82
    Total Equity14,348.9312,433.6310,714.409,435.008,847.33
    Total Equity Growth (%)15.4016.0513.566.6417.06
    Current Ratio (x)2.552.762.612.351.76
    Total Debt to Equity (x)0.120.090.120.140.30
    Contingent Liabilities0.00995.22210.67410.26425.90
    AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Total Assets17,261.1315,595.6014,037.8012,731.2213,169.17
    Total Assets Growth (%)10.6811.1010.26-3.3322.25
    Total Liabilities3,262.373,273.773,483.193,381.374,425.51
    Total Liabilities Growth (%)-0.35-6.013.01-23.5940.63
    Total Equity13,998.7612,321.8310,554.619,349.858,743.66
    Total Equity Growth (%)13.6116.7412.896.9314.66
    Current Ratio (x)2.852.922.592.221.66
    Total Debt to Equity (x)0.040.030.090.120.26
    Contingent Liabilities0.001,071.66124.49323.65359.22

    All figures in Rs Cr, unless mentioned otherwise

    View Details
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Net Cash flow from Operating Activities1,963.031,912.841,948.071,682.501,111.02
    Net Cash used in Investing Activities-1,667.21-1,298.76-1,008.50112.84-1,435.13
    Net Cash flow from Financing Activities-503.40-810.99-1,145.01-1,760.82379.57
    Net Cash Flow-222.04-186.40-207.4941.6257.96
    Closing Cash & Cash Equivalent-342.13-120.0966.31273.80232.18
    Closing Cash & Cash Equivalent Growth (%)184.89-281.10-75.7817.9333.27
    Total Debt/ CFO (x)0.830.560.620.782.32
    AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Net Cash flow from Operating Activities1,969.122,189.411,686.561,437.421,299.34
    Net Cash used in Investing Activities-1,461.25-1,007.41-865.60197.04-1,669.33
    Net Cash flow from Financing Activities-672.82-1,036.89-959.04-1,711.27436.59
    Net Cash Flow-164.95145.11-138.08-76.8166.60
    Closing Cash & Cash Equivalent-152.9112.04-133.075.0181.82
    Closing Cash & Cash Equivalent Growth (%)-1,370.02-109.05-2,756.09-93.88437.58
    Total Debt/ CFO (x)0.270.170.570.781.73

    All figures in Rs Cr, unless mentioned otherwise

    Insights

    • Increase in Cash from Investing

      Company has used Rs 1667.21 cr for investing activities which is an YoY increase of 28.37%. (Source: Consolidated Financials)
    View Details
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Return on Equity (%)16.6518.0617.4110.8819.05
    Return on Capital Employed (%)19.9219.2919.4915.0720.63
    Return on Assets (%)11.0212.2411.527.1511.69
    Interest Coverage Ratio (x)22.3224.7022.7417.0042.31
    Asset Turnover Ratio (x)0.760.780.860.830.72
    Price to Earnings (x)27.5526.9532.8941.3226.32
    Price to Book (x)4.594.875.734.495.01
    EV/EBITDA (x)17.7819.3923.1221.7519.61
    EBITDA Margin (%)24.3923.1820.1815.7320.83
    AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Return on Equity (%)16.3018.5116.5512.1317.62
    Return on Capital Employed (%)18.7618.6818.5414.5919.80
    Return on Assets (%)13.2214.6212.448.9111.70
    Interest Coverage Ratio (x)52.0134.9927.7319.0253.04
    Asset Turnover Ratio (x)0.590.590.730.700.74
    Price to Earnings (x)27.8625.6433.9035.8428.09
    Price to Book (x)4.534.735.604.344.95
    EV/EBITDA (x)21.0321.6525.9624.0921.49
    EBITDA Margin (%)30.8330.2123.2918.1422.76

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP

Technicals

  • Stochastic Crossover

    Bearish signal on weekly chart

    Appeared on: 5 Jun 2026

    Region: Equlibrium

    Last Signal 30 Apr 2026 (Loss -1.61%)

    Average price decline of -5.42% within 7 weeks of Bearish signal in last 10 years

  • 47%
    Positive Movement
    since 1st Jan 2005
    on basis
    53%
    Negative Movement
    since 1st Jan 2005
    on basis
    Exclude

    Global Meltdown1st Jan 2008 to 10th Nov 2008

    Covid Crisis1st Feb 2020 to 31st Mar 2020

  • R15417.67Pivot

    5351.83

    		S15233.67
    R25535.83S25167.83
    R35719.83S34983.83
  • 5 Days14 Days28 Days
    161.66160.96156.74

Found Technicals useful?

Peer Comparison

Found Peer Comparison useful?

Shareholding Pattern

  • CategoryNo. of SharesPercentage% Change QoQ
    Promoters6,12,13,10951.20 %0.00
    Pledge00.00 %0.00
    FII1,21,43,05110.15 %0.17
    DII2,55,85,22521.39 %-0.14
    MF1,86,14,48715.57 %-0.48
    Others2,06,23,61517.25 %-0.03
  • CategoryMar 2026Dec 2025Sep 2025Jun 2025
    Promoters51.2051.2051.2053.04
    Pledge0.000.000.000.00
    FII10.159.979.479.11
    DII21.3921.5421.9321.80
    Mutual Funds15.5716.0616.9416.67
    Others17.2517.2817.4016.04

Mutual Funds Ownership

MF Ownership as on 30 April 2026

View all Mutual Fund Schemes

Alkem Labs Futures & Options

    DatePriceOpen Interest

    30-06-2026Current

    101.75-28.35 (-21.79%)

    18,625625 (3.47%)

    145.00
    Open
    200.65
    High
    98.00
    Low
    130.10
    Close
    174
    Contracts Traded
    1,194.52
    Turnover (₹ Lakhs)

    Open Interest as of 10 Jun 2026

    • Expiry Month
    DatePriceOpen Interest

    30-06-2026Current

    5,310.50-61.00 (-1.14%)

    13,58,75013,875 (1.03%)

    5,380.00
    Open
    5,487.50
    High
    5,298.00
    Low
    5,371.50
    Prev Close
    1,100
    Contracts Traded
    7,417.65
    Turnover (₹ Lakhs)

    Open Interest as of 10 Jun 2026

Alkem Labs Top Searches

    Corporate Actions

    • Final

      500%

      May 29, 2026

      Board Meeting

      Audited Results & Final Dividend

      May 19, 2026

      Interim Dividend

      2150%

      Feb 13, 2026

    • Announced onMeeting on
      May 19, 2026May 28, 2026
      Audited Results & Final Dividend
      Jan 23, 2026Feb 13, 2026
      Quarterly Results & Interim Dividend
      Oct 23, 2025Nov 13, 2025
      Quarterly Results
      Aug 04, 2025Aug 12, 2025
      Quarterly Results
      May 16, 2025May 29, 2025
      Audited Results & Final Dividend
    • Announced onEx-DateDividend%
      Feb 13, 2026Feb 20, 20262150%
      May 29, 2025Aug 08, 2025400%
      Jan 28, 2025Feb 14, 20251850%
      May 29, 2024Aug 09, 2024250%
      May 29, 2026-500%

    • No Data Available

    • No Data Available

    • No Data Available

    • Announced onMeeting on
      Jul 03, 2025Aug 05, 2025
      -
      Jun 12, 2025Jul 14, 2025
      -
      May 29, 2025Aug 25, 2025
      -
      Sep 05, 2024Oct 05, 2024
      -
      May 29, 2024Aug 30, 2024
      -

    About Alkem Labs

    Alkem Laboratories Ltd., incorporated in the year 1973, is a Large Cap company (having a market cap of Rs 63,363.47 Crore) operating in Pharmaceuticals sector.

    Show More

    Industry

    Pharma - Indian

    Key Indices Listed On

    Nifty Midcap 100, Nifty 200, Nifty 500, BSE 500, Nifty Pharma

    Address

    Alkem House,Senapati Bapat Marg,Lower Parel,Mumbai, Maharashtra - 400013

    Contact

    investors@alkem.com

    http://www.alkemlabs.com

    Executive Leadership

    BN

    Basudeo N Singh

    Executive Chairman
    SS

    Sandeep Singh

    Managing Director
    VG

    Vikas Gupta

    Chief Executive Officer
    MS

    Madhurima Singh

    Executive Director
    Show More

    Auditors

    Deloitte Haskins & Sells LLP
    BSR & Co. LLP

    FAQs about Alkem Labs share

    • 1. What is Alkem Labs share price and what are the returns for Alkem Labs share?
      As on 11 Jun, 2026, 09:06 AM IST Alkem Labs share price is down by 0.25% basis the previous closing price of Rs 5,355.5. Alkem Labs share price is Rs 5,286.50. Return Performance of Alkem Labs Shares:
      • 1 Week: Alkem Labs share price moved up by 0.19%
    • 2. What are the returns for Alkem Labs share?
      Return Performance of Alkem Labs Shares:
      • 1 Week: Alkem Labs share price moved up by 0.19%
    • 3. What has been highest price of Alkem Labs share in last 52 weeks?
      In last 52 weeks Alkem Labs share had a high price of Rs 5,933.50 and low price of Rs 4,716.20
    • 4. What is the market cap of Alkem Labs?
      Within the Pharmaceuticals sector, Alkem Labs stock has a market cap rank of 12. Alkem Labs has a market cap of Rs 63,363.47 Cr.
    • 5. What is the PE & PB ratio of Alkem Labs?
      The PE ratio of Alkem Labs stands at 27.53, while the PB ratio is 4.42.

    Top Gainers

    As on 03:59 PM | 10 Jun 2026
    Inox India
    1,891.60
    204.90 (12.15%)
    Akums Drugs & Pharma
    592.10
    43.86 (8.00%)
    Chambal Fertilisers
    477.65
    22.90 (5.04%)
    Afcons Infrastru
    330.05
    14.56 (4.62%)
    Concord Biotech Ltd.
    1,330.70
    58.50 (4.60%)

    Top Losers

    As on 03:59 PM | 10 Jun 2026
    Oil India Ltd
    427.35
    -48.60 (-10.22%)
    IFCI
    71.83
    -5.24 (-6.80%)
    Manappuram Finance
    288.25
    -19.00 (-6.19%)
    Jindal Saw
    225.16
    -14.66 (-6.11%)
    NLC India
    309.60
    -18.15 (-5.54%)

    Equity Quick Links

    Top Gainers
    Top Losers
    Hourly gainers
    Hourly losers
    Sensex
    Nifty
    NSE
    BSE
    Midcap stocks
    Smallcap stocks
    Largecap stocks
    Sensex
    Nifty
    NSE
    BSE
    MCX Live

    More from Markets

    IPO
    Stock market news
    Budget 2022 Live Updates
    Cryptocurrency
    Currency converter
    NSE holiday list

    Trending in Markets

    DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

    DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

    By using this site, you agree to the Terms of Service and Privacy Policy.

    Business News › Markets › Stocks › Stock Price Quotes › Alkem Labs Share Price

    Browse Companies

    ABCDEFGHIJKLMNOPQRSTUVWXYZ
    123456789

    Popular Categories

    Hot on Web

    In Case you missed it

    Top Searched Companies

    Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
    Times Syndication Service

    Do Not Sell My Personal Information